VIKING THERAPEUTICS INC (1VKTX.MI) Stock Earnings & Estimates
Europe - Euronext Milan - BIT:1VKTX - US92686J1060 - Common Stock
32.86 EUR
+0.7 (+2.19%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A -96.23% | N/A 33,729.28% | N/A 510.91% | N/A 158.54% | N/A 77.73% | N/A 52.75% | |||||||||||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A -21.76% | N/A -30.72% | N/A -38.37% | N/A -17.68% | -100.535M -45.16% | -150.575M -49.77% | N/A -100.22% | N/A -16.21% | N/A -23.16% | N/A -15.48% | N/A 19.81% | N/A 136.25% | N/A 371.16% | N/A 92.39% | |
| EBIT YoY % growth | -12M | -13.85M -15.42% | -19.07M -37.69% | -26.16M -37.18% | -32.69M -24.96% | -42.66M -30.50% | -55.68M -30.52% | -70.36M -26.36% | -100.827M -43.30% | -150.921M -49.68% | N/A -107.50% | N/A -25.42% | N/A -15.58% | N/A -20.69% | N/A 35.12% | N/A 187.69% | N/A 299.10% | N/A 95.26% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | -3.56 | -1.00 71.91% | -0.80 20.00% | -0.39 51.25% | -0.36 7.69% | -0.54 -50.00% | -0.72 -33.33% | -0.91 -26.39% | -0.92 -1.10% | -1.00 -8.70% | N/A -168.74% | N/A -37.46% | N/A -11.34% | N/A 6.83% | N/A 71.25% | N/A 525.74% | N/A 145.54% | N/A 73.73% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.89 -179.11% | -0.96 -134.92% | -1.01 -73.35% | -0.97 -19.63% | -0.99 -10.32% | -0.80 17.40% | -0.91 9.71% | -0.96 1.05% | -0.97 1.66% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | |||||
| EBITDA Q2Q % growth | -100.667M -119.36% | -92.556M -67.20% | -95.541M -28.50% | -93.539M -13.64% | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -108.519M -134.70% | -113.391M -104.42% | -118.763M -59.26% | -121.473M -23.25% | -130.884M -20.61% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.81 -268.18% | -0.69 | -0.12 | -17.21% |
| Q2 2025 Q2Q % growth | -0.58 -190.00% | -0.46 | -0.12 | -27.37% |
| Q1 2025 Q2Q % growth | -0.41 -57.69% | -0.33 | -0.08 | -23.91% |
| Q4 2024 Q2Q % growth | -0.32 -28.00% | -0.28 | -0.04 | -13.70% |
| Q3 2024 Q2Q % growth | -0.22 4.35% | -0.26 | 0.04 | 14.36% |
| Q2 2024 Q2Q % growth | -0.20 -5.26% | -0.28 | 0.08 | 27.38% |
| Q1 2024 Q2Q % growth | -0.26 -4.00% | -0.28 | 0.02 | 8.31% |
| Q4 2023 Q2Q % growth | -0.25 3.85% | -0.26 | 0.01 | 3.25% |
| Q3 2023 Q2Q % growth | -0.23 -9.52% | -0.22 | -0.01 | -2.92% |
| Q2 2023 Q2Q % growth | -0.19 17.39% | -0.20 | 0.01 | 3.16% |
| Q1 2023 Q2Q % growth | -0.25 -19.05% | -0.24 | -0.01 | -2.12% |
| Q4 2022 Q2Q % growth | -0.26 -62.50% | -0.24 | -0.02 | -9.97% |
| Q3 2022 Q2Q % growth | -0.21 -23.53% | -0.24 | 0.03 | 10.87% |
| Q2 2022 Q2Q % growth | -0.23 -15.00% | -0.22 | -0.01 | -6.36% |
| Q1 2022 Q2Q % growth | -0.21 -10.53% | -0.20 | -0.01 | -5.88% |
| Q4 2021 Q2Q % growth | -0.16 -6.67% | -0.19 | 0.03 | 16.46% |
| Q3 2021 Q2Q % growth | -0.17 -30.77% | -0.21 | 0.04 | 19.48% |
| Q2 2021 Q2Q % growth | -0.20 -53.85% | -0.20 | 0.00 | 0.78% |
| Q1 2021 Q2Q % growth | -0.19 -46.15% | -0.18 | -0.01 | -7.14% |
| Q4 2020 Q2Q % growth | -0.15 -50.00% | -0.16 | 0.01 | 3.59% |
| Q3 2020 Q2Q % growth | -0.13 -62.50% | -0.15 | 0.02 | 16.04% |
| Q2 2020 Q2Q % growth | -0.13 -18.18% | -0.15 | 0.02 | 10.92% |
| Q1 2020 Q2Q % growth | -0.13 -85.71% | -0.12 | -0.01 | -4.93% |
| Q4 2019 Q2Q % growth | -0.10 | -0.13 | 0.03 | 23.45% |
| Q3 2019 Q2Q % growth | -0.08 | -0.13 | 0.05 | 37.84% |
| Q2 2019 Q2Q % growth | -0.11 | -0.09 | -0.02 | -19.83% |
| Q1 2019 Q2Q % growth | -0.07 | -0.09 | 0.02 | 19.79% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -21.26% | -18.09% | -8.77% | -9.84% |
| Revenue | N/A | N/A | N/A | N/A |